8-K current report · filed Nov 18, 2026

Align Technology (ALGN) 8-K Current Report: November 18, 2026

Item 5.02Item EX-99.1ALGN overview

Short answer

Align Technology (ALGN) filed an 8-K current report with the SEC on November 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). Board expands from 11 to 13 directors, adding Paul Clancy immediately and Ian Bell effective December 10, 2026.

Align Technology 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Board expands from 11 to 13 directors, adding Paul Clancy immediately and Ian Bell effective December 10, 2026
  • Both nominees expected to stand for shareholder election at the May 2027 annual meeting
  • Prorated non-employee director retainers and equity grants create incremental governance-related compensation costs
  • No disclosed related-party transactions or selection arrangements, reducing immediate conflict-of-interest concerns

Item EX-99.1 · Exhibit EX-99.1

  • Paul J. Clancy appointed director immediately, adding former Alexion and Biogen CFO expertise
  • Ian Bell joins December 10, 2026, bringing Alcon commercial, manufacturing, quality and regulatory experience
  • Board expands to 13 directors, then declines to 12 after C. Raymond Larkin Jr.’s December 31 retirement
  • Both nominees will stand for shareholder election at Align’s 2027 annual meeting
  • Appointments strengthen financial oversight and healthcare operating expertise as Align pursues long-term growth strategy

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Align Technology 8-K filings

Get the next ALGN 8-K as it lands

Follow ALGN for push alerts, or ask the research agent what this filing means.